Hutch News

Hutch News

Stories tagged 'Nicole Urban'

Squelching ovarian cancer: the not-so-silent killer

The search continues for new biomarkers, better outcomes and, yes, cures for this deadly disease

Sept. 17, 2018 | By Diane Mapes / Fred Hutch News Service

September is Ovarian Cancer Awareness Month, but Fred Hutch researchers are working year-round to find ways to detect the disease early and shut it down for good. Read on for a handful of ovarian cancer research highlights.

View story >

Good News at Fred Hutch

Celebrating faculty and staff achievements

April 15, 2016

Gay City was among three community groups to receive funding this year from the Fred Hutch Health Disparities Research Center. Shown here are community organizer Emmet Stanfield and Kathy Ulrich, development director.

View story >

Arnold floor named to honor Canary Foundation

Urban, Hanash and several other early detection researchers are foundation grant recipients

Aug. 30, 2010 | By Christi Ball Loso

The fifth floor of the Arnold Building, which houses the labs of Drs. Nicole Urban and Samir Hanash, has a new name in honor of the Cancary Foundation, which funds the Fred Hutchinson Cancer Research Center’s early cancer detection research.

View story >

Early markers of ovarian cancer

Public Health Sciences Division finding that biomarkers may show up years ahead of diagnosis is a step forward in early detection efforts

Jan. 11, 2010

Concentrations of three biomarkers begin to rise three years before women are diagnosed ovarian cancer, according to a new study by Fred Hutchinson Cancer Research Center Public Health Sciences Division researchers published online Dec. 30 in the Journal of the National Cancer Institute. However, the study found the biomarkers become substantially elevated only in the last year prior to diagnosis.

View story >

Predicting the path of resistance

New study reveals why certain ovarian cancers develop resistance to platinum-based chemotherapy drugs

Feb. 11, 2008 | By Kristen Woodward

A new mechanism, at the Hutchinson Center unlike any previously identified, may help explain why some recurrent ovarian tumors become resistant to treatment with commonly used platinum-based chemotherapy drugs such as cisplatin and carboplatin.

View story >

Signs from a silent killer

Simple evaluation of symptoms may be first screening test for ovarian cancer

Jan. 2, 2007

A symptom survey may provide clinicians with a rapid, cost-effective screening tool to detect early stages of ovarian cancer, according to a new study led by Dr. Barbara Goff of the Clinical Research Division of Hutchinson Center, Seattle Cancer Care Alliance and University of Washington School of Medicine.

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.